ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,858 | -1.3% | 13,562 | +10.2% | 0.00% | 0.0% |
| Q2 2023 | $384,790 | -19.7% | 12,309 | -27.5% | 0.00% | 0.0% |
| Q1 2023 | $479,046 | +16.8% | 16,982 | +8.1% | 0.00% | 0.0% |
| Q4 2022 | $410,065 | +17.8% | 15,705 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $348,000 | -18.9% | 15,582 | +8.1% | 0.00% | 0.0% |
| Q2 2022 | $429,000 | +4.1% | 14,417 | -7.9% | 0.00% | 0.0% |
| Q1 2022 | $412,000 | +14.4% | 15,656 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $360,000 | +110.5% | 15,465 | +180.4% | 0.00% | – |
| Q3 2021 | $171,000 | +66.0% | 5,516 | +30.7% | 0.00% | – |
| Q2 2021 | $103,000 | +21.2% | 4,221 | -7.8% | 0.00% | – |
| Q1 2021 | $85,000 | +3.7% | 4,576 | +12.0% | 0.00% | – |
| Q4 2020 | $82,000 | +22.4% | 4,085 | +0.3% | 0.00% | – |
| Q3 2020 | $67,000 | +26.4% | 4,074 | +50.3% | 0.00% | – |
| Q2 2020 | $53,000 | +29.3% | 2,710 | -5.2% | 0.00% | – |
| Q1 2020 | $41,000 | – | 2,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |